MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
-6.09%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$187M
AUM Growth
+$187M
(-8.4%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-6.14%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$11.4M |
| 2 |
ONCR
Oncorus, Inc.
ONCR
|
$115K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $69.9M | 37.45% | 4,425,784 | – | – |
|
2
Dyne Therapeutics
DYN
$1.92B
| $44.4M | 23.76% | 4,951,303 | – | – |
|
3
iTeos Therapeutics
ITOS
| $30M | 16.06% | 2,738,785 | – | – |
|
4
Repare Therapeutics
RPTX
$71.7M
| $27.1M | 14.51% | 2,242,636 | – | – |
|
5
Werewolf Therapeutics
HOWL
$59.9M
| $9.17M | 4.91% | 4,284,172 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.9M | 2.63% | 6,287,101 | – | – |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.26M | 0.68% | 313,136 -2,818,252 | -90% | -$11.4M |
|
|
ONCR
8
DELISTED
Oncorus, Inc.
ONCR
| – | – | -2,849,464 | Closed | -$115K |
|